Guidance on the use of increased infectious risk donors for organ transplantation.
出版信息
Transplantation. 2014 Aug 27;98(4):365-9. doi: 10.1097/TP.0000000000000251.
Abstract
摘要
相似文献
1
Guidance on the use of increased infectious risk donors for organ transplantation.
Transplantation. 2014 Aug 27;98(4):365-9. doi: 10.1097/TP.0000000000000251.
2
High infectious risk donors: what are the risks and when are they too high?
Curr Opin Organ Transplant. 2011 Apr;16(2):256-61. doi: 10.1097/MOT.0b013e3283449dd3.
3
Donor-derived infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Clin Transplant. 2019 Sep;33(9):e13547. doi: 10.1111/ctr.13547. Epub 2019 Apr 10.
4
Informing candidates for solid-organ transplantation about donor risk factors.
N Engl J Med. 2008 Jun 26;358(26):2832-7. doi: 10.1056/NEJMsb0800674.
5
Informing candidates for transplantation about donor risk factors.
N Engl J Med. 2008 Sep 11;359(11):1182; author reply 1182-3. doi: 10.1056/NEJMc081540.
6
Informing candidates for transplantation about donor risk factors.
N Engl J Med. 2008 Sep 11;359(11):1182; author reply 1182-3.
7
Infectious disease complications of transplant tourism.
Expert Rev Anti Infect Ther. 2021 Jun;19(6):671-673. doi: 10.1080/14787210.2020.1851196. Epub 2021 Jan 8.
8
Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12791. Epub 2017 Nov 3.
9
Arboviruses Recommendations for Solid-Organ Transplant Recipients and Donors.
Transplantation. 2018 Feb;102(2S Suppl 2):S42-S51. doi: 10.1097/TP.0000000000002011.
10
Evaluating the risk of transmission of infection from donor to recipient of a solid organ transplantation.
Enferm Infecc Microbiol Clin. 2012 Mar;30 Suppl 2:19-26. doi: 10.1016/S0213-005X(12)70078-2.
引用本文的文献
1
Sexual and gender minoritized persons in organ and tissue donation: a qualitative analysis.
Can J Anaesth. 2025 Jul 15. doi: 10.1007/s12630-025-03011-4.
2
Differential effects of donor factors on post-transplant survival in lung transplantation.
JHLT Open. 2024 Jul 1;5:100122. doi: 10.1016/j.jhlto.2024.100122. eCollection 2024 Aug.
3
Increased Infectious Risk Donor Status and Equity-Relevant Predictors of Organ Donation Organization Approach and Caregiver Consent for Deceased Organ Donation in a Canadian Province (2015-2021).
Clin Transplant. 2024 Dec;38(12):e70058. doi: 10.1111/ctr.70058.
4
Organ Donation Organization Architecture: Recommendations From an International Consensus Forum.
Transplant Direct. 2023 Apr 28;9(5):e1440. doi: 10.1097/TXD.0000000000001440. eCollection 2023 May.
5
Hepatitis C positive organ transplantation to negative recipients at a multiorgan Canadian transplant centre: ready for prime time.
BMC Gastroenterol. 2022 Jan 25;22(1):34. doi: 10.1186/s12876-022-02107-1.
6
The 3-T Model of Informed Consent for Nonstandard Risk Donors: A Proposal for Transplant Clinical Practice.
Transplant Direct. 2021 Oct 22;7(11):e782. doi: 10.1097/TXD.0000000000001238. eCollection 2021 Nov.
7
Successful Use of Kidneys from a Deceased Donor with Active Herpes Zoster Infection.
Case Rep Transplant. 2021 Aug 16;2021:7719041. doi: 10.1155/2021/7719041. eCollection 2021.
8
Expanding the Deceased Donor Pool in Manitoba Using Hepatitis C-Viremic Donors: Program Report.
Can J Kidney Health Dis. 2021 Jul 26;8:20543581211033496. doi: 10.1177/20543581211033496. eCollection 2021.
9
Outcomes After Declining Increased Infectious Risk Kidney Offers for Pediatric Candidates in the United States.
Transplantation. 2019 Dec;103(12):2558-2565. doi: 10.1097/TP.0000000000002674.
10
Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission.
Transplant Direct. 2018 Dec 20;5(1):e416. doi: 10.1097/TXD.0000000000000852. eCollection 2019 Jan.
本文引用的文献
1
PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.
Public Health Rep. 2013 Jul;128(4):247-343. doi: 10.1177/003335491312800403.
2
The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.
Addiction. 2012 Jul;107(7):1318-27. doi: 10.1111/j.1360-0443.2012.03803.x. Epub 2012 Mar 22.
3
Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs.
PLoS One. 2011;6(7):e22245. doi: 10.1371/journal.pone.0022245. Epub 2011 Jul 20.
4
Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada.
AIDS. 2011 Sep 24;25(15):1897-903. doi: 10.1097/QAD.0b013e32834ad6bb.
5
Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients.
Am J Transplant. 2011 Jun;11(6):1218-25. doi: 10.1111/j.1600-6143.2011.03597.x.
6
Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States.
Am J Transplant. 2011 Jun;11(6):1201-8. doi: 10.1111/j.1600-6143.2011.03518.x.
7
Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.
Am J Transplant. 2011 Jun;11(6):1188-200. doi: 10.1111/j.1600-6143.2011.03460.x. Epub 2011 Mar 14.
8
Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis.
Am J Transplant. 2011 Jun;11(6):1176-87. doi: 10.1111/j.1600-6143.2010.03329.x. Epub 2011 Mar 2.
9
Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study.
Am J Epidemiol. 2011 May 1;173(9):1049-58. doi: 10.1093/aje/kwq479. Epub 2011 Mar 1.
10
Determining rates of hepatitis C in a clozapine treated cohort.
Schizophr Res. 2010 Dec;124(1-3):86-90. doi: 10.1016/j.schres.2010.06.005. Epub 2010 Jul 6.
Zotero 插件